The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123253046 12325304 6 F 20150901 20160815 20160502 20160819 EXP GB-TAKEDA-2016MPI003559 TAKEDA 87.00 YR M Y 82.00000 KG 20160819 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123253046 12325304 1 PS VELCADE BORTEZOMIB 1 Subcutaneous 1.8 MG, UNK Y Z1501508 21602 1.8 MG INJECTION
123253046 12325304 2 SS VELCADE BORTEZOMIB 1 Subcutaneous 1.8 MG, UNK Y Z1501508 21602 1.8 MG INJECTION
123253046 12325304 3 SS PREDNISONE. PREDNISONE 1 Oral 10 MG, UNK Y MQ0401001 0 10 MG TABLET
123253046 12325304 4 SS DARATUMUMAB DARATUMUMAB 1 Intravenous (not otherwise specified) 1100 MG, 3/WEEK Y MQ0401001 0 1100 MG TIW
123253046 12325304 5 SS MELPHALAN MELPHALAN 1 Oral 10 MG, UNK Y 0 10 MG
123253046 12325304 6 C FILGRASTIM FILGRASTIM 1 Subcutaneous 300 ?G, UNK 0 300 UG INJECTION
123253046 12325304 7 C FILGRASTIM FILGRASTIM 1 Subcutaneous 300 ?G, UNK 0 300 UG INJECTION
123253046 12325304 8 C CIPROFLOXACIN. CIPROFLOXACIN 1 Oral 500 MG, BID 5000 MG 0 500 MG CAPSULE BID
123253046 12325304 9 C COTRIMOXAZOLE SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 480 MG, UNK 0 480 MG CAPSULE
123253046 12325304 10 C COTRIMOXAZOLE SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 480 MG, UNK 0 480 MG CAPSULE
123253046 12325304 11 C ACICLOVIR ACYCLOVIR 1 Oral 400 MG, BID 0 400 MG CAPSULE BID
123253046 12325304 12 C CALCICHEW CALCIUM CARBONATE 1 Oral 2.25 G, UNK 0 2.25 G TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123253046 12325304 1 Plasma cell myeloma
123253046 12325304 3 Plasma cell myeloma
123253046 12325304 4 Plasma cell myeloma
123253046 12325304 5 Plasma cell myeloma
123253046 12325304 6 Prophylaxis
123253046 12325304 8 Infection prophylaxis
123253046 12325304 9 Infection prophylaxis
123253046 12325304 11 Infection prophylaxis
123253046 12325304 12 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
123253046 12325304 HO
123253046 12325304 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123253046 12325304 Anaemia
123253046 12325304 Ear infection
123253046 12325304 Hypoproteinaemia
123253046 12325304 Infection
123253046 12325304 Neutropenia
123253046 12325304 Upper respiratory tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123253046 12325304 1 20150817 20160411 0
123253046 12325304 2 20160503 0
123253046 12325304 3 20150817 20160317 0
123253046 12325304 4 20150817 20160404 0
123253046 12325304 5 20150817 20160317 0
123253046 12325304 6 20160223 20160225 0
123253046 12325304 7 20150908 20150909 0
123253046 12325304 8 20150910 20150914 0
123253046 12325304 9 20150910 0
123253046 12325304 10 20160118 0
123253046 12325304 11 20160118 0
123253046 12325304 12 20160201 0